Ponvory — Cigna
multiple sclerosis
Preferred products
- generic fingolimod capsules
- generic dimethyl fumarate delayed-release capsules
Initial criteria
- Patient meets BOTH of the following (A and B):
- A) Patient meets the standard Multiple Sclerosis – Ponvory Prior Authorization Policy criteria; AND
- B) Patient meets ONE of the following (i or ii):
- i. Patient has been established on Ponvory for ≥ 120 days; OR
- ii. Patient meets BOTH of the following (a and b):
- a) Patient meets BOTH of the following [(1) and (2)]:
- (1) Patient has tried generic dimethyl fumarate delayed-release capsules [documentation required]; AND
- (2) Patient has experienced inadequate efficacy or significant intolerance according to the prescriber [documentation required];
- b) Patient meets BOTH of the following [(1) and (2)]:
- (1) Patient has tried generic fingolimod capsules [documentation required]; AND
- (2) Patient has experienced inadequate efficacy or significant intolerance according to the prescriber [documentation required].
Approval duration
1 year